Literature DB >> 21183876

Liver repopulation by transplanted hepatocytes in a rat model of acute liver failure induced by carbon tetrachloride and a partial hepatectomy.

Satoshi Mochizuki1, Yujo Kawashita, Susumu Eguchi, Mitsuhisa Takatsuki, Kosho Yamanouchi, Hirotaka Tokai, Masaaki Hidaka, Akihiko Soyama, Shigeki Nagayoshi, Takashi Kanematsu.   

Abstract

BACKGROUND: Although hepatocyte transplantation holds great promise, most of the transplanted hepatocytes fail to proliferate in the liver without any manipulation of the host. Previous studies have shown that the replacement of the host liver cells with transplanted hepatocytes, called "liver repopulation", requires a combination of proliferative stimuli to the transplanted hepatocytes and suppression of the host hepatocytes. This study explored whether liver repopulation could be achieved by hepatocyte transplantation in a chemically and surgically induced-liver failure model in the rat. MATERIAL/
METHODS: Dipeptidyl peptidase IV-positive (DPPIV +) Fisher rats were used as donor and syngeneic DPPIV-deficient (DPPIV-) rats served as recipient. The recipient rats were treated with carbon tetrachloride (CCl4) for 4 weeks followed by a 68% partial hepatectomy (PH) and transplantation of the hepatocytes (HT). Five groups were established based on the influence of specific factors including CCl4, PH, and HT. The liver regeneration rates were evaluated by the liver weight/body weight (LW/BW) ratio. The liver repopulation rates were determined by the formula; (DPPIV+ cell counts/all cell counts) ×100%.
RESULTS: The liver regeneration rates were 3.5 and 2.6 in the rats with CCl4+PH, and PH alone, respectively (P<0.01). In the rats with CCl4+PH, DPPIV positive cell clusters appeared in the host liver parenchyma 7 days after HT (day 7), exhibiting continuous proliferation up to day 28 (The liver repopulation rates were 1.1% and 13.4%, respectively, p<0.05).
CONCLUSIONS: Liver repopulation by hepatocyte transplantation was therefore found to be possible in partially hepatectomized rats under the continuous exposure to regulated doses of CCl4.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21183876

Source DB:  PubMed          Journal:  Ann Transplant        ISSN: 1425-9524            Impact factor:   1.530


  5 in total

1.  Expression of glutathione S-transferase A1, a phase II drug-metabolizing enzyme in acute hepatic injury on mice.

Authors:  Xin Ma; Fangping Liu; Minmin Li; Zhi Li; Yuexia Lin; Rui Li; Changwen Li; Yicong Chang; Changwei Zhao; Qing Han; Qiong Zhou; Yulin Zhao; Dening Wang; Jingli Liu
Journal:  Exp Ther Med       Date:  2017-08-17       Impact factor: 2.447

Review 2.  Human hepatocyte transplantation for liver disease: current status and future perspectives.

Authors:  V Iansante; R R Mitry; C Filippi; E Fitzpatrick; A Dhawan
Journal:  Pediatr Res       Date:  2017-12-06       Impact factor: 3.756

Review 3.  Progress in abdominal organ transplantation.

Authors:  Maciej Kosieradzki; Wojciech Lisik; Wojciech Rowiński; Piotr Małkowski
Journal:  Med Sci Monit       Date:  2011-12

4.  Improving engraftment of hepatocyte transplantation using alpha-1 antitrypsin as an immune modulator.

Authors:  Charlotte Lee; Anil Dhawan; Valeria Iansante; Celine Filippi; Ragai Mitry; Joanne Tang; Simon Walker; Raquel Fernandez DaCosta; Siddharth Sinha; Robin D Hughes; Maria Koulmanda; Emer Fitzpatrick
Journal:  J Mol Med (Berl)       Date:  2019-02-28       Impact factor: 4.599

5.  In utero hepatocellular transplantation in rats.

Authors:  Emma Muñoz-Sáez; Estefanía de Munck; Paloma Maganto; Cristina Escudero; Begoña G Miguel; Rosa María Arahuetes
Journal:  Clin Dev Immunol       Date:  2013-08-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.